{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:05Z","timestamp":1786993625281,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jvs.2014.03.293","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T21:46:41Z","timestamp":1401227201000},"page":"993-1001","source":"Crossref","is-referenced-by-count":40,"title":["Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease"],"prefix":"10.1016","volume":"60","author":[{"given":"Baolei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2014.03.293_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"Gent","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2014.03.293_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2014.03.293_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.avsg.2012.05.001","article-title":"Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures","volume":"27","author":"Allemang","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2014.03.293_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2010.05.013","volume":"56","author":"Holmes","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.03.293_bib5","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.03.293_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2006.10.050","article-title":"Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?","volume":"49","author":"Bliden","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.03.293_bib7","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.03.293_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/clpt.2013.105","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update","volume":"94","author":"Scott","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jvs.2014.03.293_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIR.0b013e3181d1e0e1","article-title":"Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines","volume":"121","author":"Steinhubl","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.03.293_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0091270009343005","article-title":"Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans","volume":"50","author":"Farid","year":"2010","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jvs.2014.03.293_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1592\/phco.30.3.265","article-title":"Genetic causes of clopidogrel nonresponsiveness: which ones really count?","volume":"30","author":"Momary","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jvs.2014.03.293_bib12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.110.973362","article-title":"Responding to the clopidogrel warning by the US Food and Drug Administration: real life is complicated","volume":"122","author":"Roden","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2014.03.293_bib13","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1538-7836.2005.01513.x","article-title":"Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thromboelastography","volume":"3","author":"Rivard","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvs.2014.03.293_bib14","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1253\/circj.CJ-12-0635","article-title":"Association of CYP2C19 genotype with periprocedural myocardial infarction after uneventful stent implantation in Chinese patients receiving clopidogrel pretreatment","volume":"76","author":"Wu","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2014.03.293_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ccd.21782","article-title":"Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists","volume":"1","author":"Angiolillo","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2014.03.293_bib16","first-page":"591","article-title":"Prevention and treatment of in-stent restenosis","volume":"51","author":"Bosiers","year":"2010","journal-title":"J\u00a0Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2014.03.293_bib17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/jama.2012.444","article-title":"CYP2C19 genotype and cardiovascular events","volume":"307","author":"Shuldine","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2014.03.293_bib18","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"Geisler","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2014.03.293_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2014.03.293_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2005.03.073","article-title":"Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial","volume":"46","author":"Beinart","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.03.293_bib21","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2011.1529","article-title":"Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis","volume":"306","author":"Cayla","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2014.03.293_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1067\/mva.2002.120030","article-title":"Age at onset of smoking is an independent risk factor in peripheral artery disease development","volume":"35","author":"Planas","year":"2002","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2014.03.293_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ahj.2011.06.005","article-title":"Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy","volume":"162","author":"Hochholzer","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2014.03.293_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2013.03.037","article-title":"The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study","volume":"62","author":"Gurbel","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2014.03.293_bib25","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1213\/ane.0b013e3181981fbe","article-title":"The effect of milrinone on platelet activation as determined by TEG platelet mapping","volume":"108","author":"Wesley","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jvs.2014.03.293_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1373\/clinchem.2009.137471","article-title":"Long-term aspirin and clopidogrel response evaluated by light transmission aggregometry, verify now, and thrombelastography in patients undergoing percutaneous coronary intervention","volume":"56","author":"Madsen","year":"2010","journal-title":"Clin Chem"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521414007125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521414007125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T16:56:26Z","timestamp":1538585786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521414007125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0741521414007125"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2014.03.293","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}